The transcriptional role of PML and the nuclear body (original) (raw)

• Pandolfi, P. P. et al. Structure and origin of the acute promyelocytic leukaemia myl/RARalpha cDNA and characterization of its retinoid-binding and transactivation properties. Oncogene 6, 1285– 1292 (1991).
  CAS PubMed Google Scholar
• de Thé, H. et al. The PML/RARalpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukaemia encodes a functionally altered RAR. Cell 66, 675–684 (1991).
  Article PubMed Google Scholar
• Goddard, A. D., Borrow, P. S., Freemont, P. S. & Solomon, E. Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukaemia. Science 254, 1371 –1374 (1991).
  Article CAS PubMed Google Scholar
• Kakizuka, A. et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukaemia fuses RARalpha with a novel putative transcription factor, PML. Cell 66, 663–674 (1991).
  Article CAS PubMed Google Scholar
• Melnick, A. & Licht, J. D. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukaemia. Blood 93, 3167– 3215 (1999).
  CAS PubMed Google Scholar
• He, L. Z., Merghoub, T. & Pandolfi, P. P. In vivo analysis of the molecular pathogenesis of acute promyelocytic leukaemia in the mouse and its therapeutic implications . Oncogene 18, 5278–5292 (1999).
  Article CAS PubMed Google Scholar
• Sternsdorf, T., Grotzinger, T., Jensen, K. & Will, H. Nuclear dots: actors on many stages. Immunobiology 198, 307–331 (1997).
  Article CAS PubMed Google Scholar
• Bouteille, M., Laval, M. & Dupuy-Coin, A. M. in The Cell Nucleus (ed. Busch, H)5–64 (Academic Press, New York, 1974).
• Ascoli, C. A. & Maul, G. G. Identification of a novel nuclear domain. J. Cell. Biol. 112, 785– 765 (1991).
  Article CAS PubMed Google Scholar
• Dyck, J. et al. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76, 333– 343 (1994).
  Article CAS PubMed Google Scholar
• Koken, M. H. M. et al. The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J. 13, 1073 –1083 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Weis, K. et al. Retinoic acid regulates aberrant nuclear localization of PML-RARalpha in acute promyelocytic leukemic cells. Cell 76, 345–356 (1994).
  Article CAS PubMed Google Scholar
• Hodges, M., Tissot, C., Howe, K., Grimwade, D. & Freemont, P. S. Structure, organization, and dynamics of promyelocytic leukaemia protein nuclear bodies. Am. J. Hum. Genet. 63, 297–304 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Maul, G. G. Nuclear domain 10, the site of DNA virus transcription and replication. Bioessays 20, 660–667 (1998).
  Article CAS PubMed Google Scholar
• Scheer, U. & Weisenberger, D. The nucleolus. Curr. Opin. Cell Biol. 6, 354–359 (1994).
  Article CAS PubMed Google Scholar
• Koken, M. H. et al. The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene 10, 1315– 1324 (1995).
  CAS PubMed Google Scholar
• LaMorte, V. J., Dyck, J. A., Ochs, R. L. & Evans, R. M. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body . Proc. Natl Acad. Sci. USA 95, 4991– 4996 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Alcalay, M. et al. The promyelocytic leukaemia gene product (PML) forms stable complexes with the retinoblastoma protein. Mol. Cell. Biol. 18, 1084–1093 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Zhong, S. et al. A role for PML and the nuclear body in genomic stability. Oncogene 18, 7941–7947 (1999).
  Article CAS PubMed Google Scholar
• Zhong, S. et al. PML and Daxx participate in a novel nuclear pathway for apoptosis . J. Exp. Med. 191, 631– 640 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, Y. & Xiong, Y. Mutations in human ARF exon 2 disrupt its nucleolar localization and impairs its ability to block nuclear export of MDM 2 and p53. Mol. Cell 3, 579– 591 (1999).
  Article CAS PubMed Google Scholar
• Ishov, A. M. et al. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 147, 221–234 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Zhong, S., Muller, S., Freemont, P. S., Dejean, A. & Pandolfi, P. P. Role of SUMO-1 modified PML in nuclear body formation. Blood (in the press).
• Boddy, M. N., Howe, K., Etkin, L. D., Solomon, E. & Freemont, P. S. PIC1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. Oncogene 13, 971 –982 (1996).
  CAS PubMed Google Scholar
• Müller, S., Matunis, M. J. & Dejean, A. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J. 17, 61–70 (1998).
  Article PubMed PubMed Central Google Scholar
• Kamitani, T. et al. Identification of three major sentrinization sites in PML . J. Biol. Chem. 273, 26675– 26682 (1998).
  Article CAS PubMed Google Scholar
• Matunis, M. J., Wu, J. & Blobel, G. SUMO-1 modification and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex. J. Cell Biol. 140, 499–509 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Saitoh, H. & Hinchey, J. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J. Biol. Chem. 275, 6252–6258 (2000).
  Article CAS PubMed Google Scholar
• Sternsdorf, T., Jensen, K. & Will, H. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J. Cell Biol. 139, 1621–1634 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Sternsdorf, T., Jensen, K., Reich, B. & Will, H. The nuclear dot protein Sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. J. Biol. Chem. 274, 12555–12566 (1999).
  Article CAS PubMed Google Scholar
• Li, S. J. & Hochstrasser, M. A new protease required for cell-cycle progression in yeast. Nature 398, 246–251 (1999).
  Article CAS PubMed Google Scholar
• Gong, L., Millas, S., Maul, G. G. & Yeh, E. T. Differential regulation of sentrinized proteins by a novel sentrin-specific protease. J. Biol. Chem. 275, 3355–3359 (2000).
  Article CAS PubMed Google Scholar
• Freemont, P. S., Hanson, I. M. & Trowsdale, J. A novel cysteine-rich sequence motif. Cell 64, 483–484 (1991).
  Article CAS PubMed Google Scholar
• Borden, K. L. B. & Freemont, P. S. The RING finger domain: a recent example of a sequence-structure family. Curr. Opin. Struct. Biol. 6, 395–401 (1996).
  Article CAS PubMed Google Scholar
• Kastner, P. et al. Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukaemia (APL): structural similarities with a new family of oncoproteins . EMBO J. 11, 629–642 (1992).
  Article CAS PubMed PubMed Central Google Scholar
• Perez, A. et al. PML/RAR homodimers: distinct DNA binding properties and heteromeric interactions with RAR. EMBO J. 12, 3171– 3182 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Borden, K. L. B. et al. The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML. EMBO J. 14, 1532–1541 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Lavau, C. et al. The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene 11, 871– 876 (1995).
  CAS PubMed Google Scholar
• Gaboli, M., Gandini, D., Delva, L., Wang, Z. G. & Pandolfi, P. P. Acute promyelocytic leukaemia as a model for cross-talk between interferon and retinoic acid pathways: from molecular biology to clinical applications. Leuk. Lymph. 30, 11– 22 (1998).
  Article CAS Google Scholar
• Ishov, A. M. & Maul, G. G. The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J. Cell Biol. 134, 815–826 (1996).
  Article CAS PubMed Google Scholar
• Everett, R. G., Meredith, M. & Orr, A. The ability of herpes simplex virus type 1 immediate-early protein Vmw110 to bind to a ubiquitin-specific protease contributes to its roles in the activation of gene expression and stimulation of virus replication . J. Virol. 73, 417–426 (1999).
  CAS PubMed PubMed Central Google Scholar
• Mueller, S. & Dejean, A. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption. J. Virol. 73,(1999).
• Chelbi-Alix, M. K., Quignon, F., Pelicano, L., Koken, M. H. M. & de The, H. Resistance to virus infection conferred by the interferon-induced promyelocytic leukaemia protein. J. Virol. 72, 1043–1051 (1998).
  CAS PubMed PubMed Central Google Scholar
• Everett, R. D., Orr, A. & Preston, C. M. A viral activator of gene expression functions via the ubiquitin-proteasome pathway. EMBO J. 17, 7161–7169 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Ahn, J. H. & Hayward, G. S. The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells. J. Virol. 71, 4599–4613 (1997).
  CAS PubMed PubMed Central Google Scholar
• Szekely, L. et al. The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies. J. Virol. 70, 2562–2568 (1996).
  CAS PubMed PubMed Central Google Scholar
• Swindle, C. S. et al. Human papillomavirus DNA replication compartments in a transient DNA replication system. J. Virol. 73, 1001 –1009 (1999).
  CAS PubMed PubMed Central Google Scholar
• Stadler, M. et al. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and GAS element. Oncogene 11, 2565–2573 (1995).
  CAS PubMed Google Scholar
• Guldner, H. H., Szostecki, C., Grotzinger, T. & Will, H. IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis . J. Immunol. 149, 4067– 4073 (1992).
  CAS PubMed Google Scholar
• Gongora, C. et al. Molecular cloning of a new interferon-induced PML nuclear body-associated protein. J. Biol. Chem. 272, 19457–19463 (1997).
  Article CAS PubMed Google Scholar
• Terris, B. et al. PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer. Res. 55, 1590 –1597 (1995).
  CAS PubMed Google Scholar
• Wang, Z. G. et al. Role of PML in cell growth and the retinoic acid pathway. Science 279, 1547–1551 (1998).
• Zheng, P. et al. Proto-oncogene PML controls genes devoted to MHC class I antigen presentation. Nature 396, 373– 376 (1998).
  Article CAS PubMed Google Scholar
• Larghero, J., Zassadowski, F., Rousselot, P. & Padua, R. A. Alteration of the PML proto-oncogene in leukemic cells does not abrogate expression of MHC class I antigens. Leukaemia 13, 1295 –1296 (1999).
  Article CAS Google Scholar
• Wang, Z.-G. et al. Pml is essential for multiple apoptotic pathways. Nature Genet. 20, 266–271 (1998).
  Article CAS PubMed Google Scholar
• Borden, K. L., Campbell Dwyer, E. J. & Salvato, M. S. The promyelocytic leukaemia protein PML has a pro-apoptotic activity mediated through its RING domain. FEBS Lett. 418, 30–34 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Quignon, F. et al. PML induces a novel caspase-independent death process. Nature Genet. 20, 259–265 (1998).
  Article CAS PubMed Google Scholar
• Fagioli, M. et al. Cooperation between the RING + B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival. Oncogene 16, 2905–2913 (1998).
  Article CAS PubMed Google Scholar
• Torii, S., Egan, D. A., Evans, R. A. & Reed, J. C. Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs). EMBO J. 18, 6037– 6049 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Li, H. et al. Sequestration and inhibition of daxx-mediated transcriptional repression by PML. Mol. Cell. Biol. 20, 1784– 1796 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Mu, Z. M., Chin, K. V., Liu, J. H., Lozano, G. & Chang, K. S. PML, a growth suppressor disrupted in acute promyelocytic leukaemia. Mol. Cell. Biol. 14, 6858– 6867 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Le, X. F., Yang, P. & Chang, K. S. Analysis of the growth and transformation suppressor domain of promyelocytic leukaemia gene, PML. J. Biol. Chem. 271, 130–135 (1996).
  Article CAS PubMed Google Scholar
• Ellis, N. A. et al. The Bloom’s syndrome gene product is homologous to RecQ helicases. Cell 83, 655– 666 (1995).
  Article CAS PubMed Google Scholar
• Ellis, N. A. & German, J. Molecular genetics of Bloom’s syndrome. Hum. Mol. Genet. 5, 1457– 1463 (1996).
  Article CAS PubMed Google Scholar
• Miki, Y. et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66– 71 (1994).
  Article CAS PubMed Google Scholar
• Welsch, P. L., Owens, K. N. & King, M. C. Insights into the functions of BRCA1 and BRCA 2. Trends Genet. 16, 69–74 (2000).
  Article Google Scholar
• Ahn, J. H., Brignole, E. J. r. & Hayward, G. S. Disruption of PML subnuclear domains by the acidic IE1 protein of human cytomegalovirus is mediated through interaction with PML and may modulate a RING finger-dependent cryptic transactivator function of PML. Mol. Cell. Biol. 18, 4899– 4913 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Vallian, S. et al. Transcriptional repression by the promyelocytic leukaemia protein, PML. Exp. Cell. Res. 237, 371– 382 (1997).
  Article CAS PubMed Google Scholar
• Rachez, C. et al. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398, 824 –828 (1999).
  Article CAS PubMed Google Scholar
• Naar, A. M. et al. Composite co-activator ARC mediates chromatin-directed transcriptional activation. Nature 398, 828– 832 (1999).
  Article CAS PubMed Google Scholar
• Fondell, J. D., Ge, H. & Roeder, R. G. Ligand induction of a transcriptionally active thyroid hormone receptor co-activator complex. Proc. Natl Acad. Sci. USA 93, 8329–8333 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Zhong, S. et al. A retinoic acid-dependent tumour-growth suppressive transcription complex is the target of the PML-RARα and T 18 oncoproteins. Nat. Genet. 23, 287–295 (1999).
  Article CAS PubMed Google Scholar
• Doucas, V., Tini, M., Egan, D. A. & Evans, R. M. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. Proc. Natl Acad. Sci. USA 96, 2627–2632 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Guiochon-Mantel, A. et al. Effect of PML and PML-RAR on the transactivation properties and subcellular distribution of steroid hormone receptors. Mol. Endocrinol. 9, 1791–1803 (1995).
  CAS PubMed Google Scholar
• Vallian, S. et al. Modulation of Fos-mediated AP-1 transcription by the promyelocytic leukaemia protein. Oncogene 16, 2843– 2853 (1998).
  Article CAS PubMed Google Scholar
• Vallian, S., Chin, K. V. & Chang, K. S. The promyelocytic leukaemia protein interacts with Sp1 and inhibits its transactivation of the epidermal growth factor receptor promoter. Mol. Cell. Biol. 18, 7147– 7156 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Doucas, V. & Evans, R. M. Human T-cell leukaemia retrovirus-Tax protein is a repressor of nuclear receptor signaling. Proc. Natl Acad. Sci. USA 96, 2633–2638 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Jiang, W. Q., Szekely, L., Klein, G. & Ringertz, N. Intranuclear redistribution of SV 40T, p53, and PML in a conditionally SV 40T-immortalized cell line. Exp. Cell Res. 229, 289– 300 (1996).
  Article CAS PubMed Google Scholar
• Lain, S., Midgley, C., Sparks, A., Lane, E. B. & Lane, D. P. An inhibitor of nuclear export activates the p53 response and induces the localization of HDM 2 and p53 to U 1A–positive nuclear bodies associated with the PODs. Exp. Cell Res. 248 , 457–472 (1999).
  Article CAS PubMed Google Scholar
• Gostissa, M. et al. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J. 18, 6462– 6471 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Rodriguez, M. S. et al. SUMO-1 modification activates the transcriptional response of p53. EMBO J. 18, 6455– 6461 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Chakravati, D. et al. Role of CBP/P300 in nuclear receptor signalling. Nature 383, 99–103 (1996).
  Article Google Scholar
• Bannister, A. J. & Kouzarides, T. The CBP co-activator is a histone acetyltransferase. Nature 384, 641–643 (1996).
  Article CAS PubMed Google Scholar
• Boyes, J., Byfield, P., Nakatani, Y. & Ogryzko, V. Regulation of activity of the transcription factor GATA-1 by acetylation. Nature 396(1998).
• Blobel, G. A., Nakajima, T., Eckner, R., Montminy, M. & Orkin, S. H. CREB-binding protein cooperates with transcription factor GATA-1 and is required for erythroid differentiation. Proc. Natl Acad. Sci. USA 95, 2061–2066 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, W. & Bieker, J. J. Acetylation and modulation of erythroid Kruppel-like factor (EKLF) activity by interaction with histone acetyltransferases. Proc. Natl Acad. Sci. USA 95, 9855–9860 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Remboutsika, E. et al. The putative nuclear receptor mediator TIF1alpha is tightly associated with euchromatin. J. Cell Sci. 112, 1671–1683 (1999).
  CAS PubMed Google Scholar
• Johnson, F. B. & al., e. Association of the Bloom Syndrome protein with Topoisomerase IIIalpha in somatic and meiotic cells. Cancer Res. (in the press).
• Lai, H.-K. & Borden, K. L. B. The promyelocytic leukaemia (PML) protein suppresses cyclin D 1 protein production by altering the nuclear cytoplasmic distribution of cyclin D 1 mRNA. Oncogene (in the press).
• Asano, K., Merrick, W. C. & Hershey, J. W. The translation initiation factor eIF 3-p 48 subunit is encoded by int-6, a site of frequent integration by the mouse mammary tumour virus genome. J. Biol. Chem. 272, 23477– 23480 (1997).
  Article CAS PubMed Google Scholar
• Everett, R. D. et al. A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein . EMBO J. 16, 1519–1530 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Seeler, J.S., Marchio, A., Sitterling, D., Transy, C. & Dejean, A. Interaction of Sp100 with HP 1 proteins: a link between the promyelocytic leukaemia-associated nuclear bodies and the chromatin compartment. Proc. Natl Acad. Sci. USA 95 , 7316–7321 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Bloch, D. B., de la Monte, S. M., Guigaouri, P., Filippov, A. & Bloch, K. D. Identification and characterization of a leukocyte-specific component of the nuclear body. J. Biol. Chem. 271, 29198–29204 (1996).
  Article CAS PubMed Google Scholar
• Boisvert, F. M., Hendzel, M. J. & Bazett-Jones, D. P. Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA. J. Cell Biol. 148, 283–292 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Lehming, N., Le Saux, A., Schuller, J. & Ptashne, M. Chromatin components as part of a putative transcriptional repressing complex . Proc. Natl Acad. Sci. USA 95, 7322– 7326 (1998).
  Article CAS PubMed PubMed Central Google Scholar